Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) EBT Margin (2016 - 2025)

Historic EBT Margin for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 4.26%.

  • Sanara MedTech's EBT Margin rose 49500.0% to 4.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.89%, marking a year-over-year decrease of 35400.0%. This contributed to the annual value of 11.33% for FY2024, which is 45000.0% down from last year.
  • Per Sanara MedTech's latest filing, its EBT Margin stood at 4.26% for Q3 2025, which was up 49500.0% from 7.06% recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's EBT Margin peaked at 4.26% during Q3 2025, and registered a low of 50.57% during Q4 2021.
  • Its 5-year average for EBT Margin is 18.21%, with a median of 16.35% in 2021.
  • As far as peak fluctuations go, Sanara MedTech's EBT Margin plummeted by -327600bps in 2021, and later soared by 277100bps in 2023.
  • Quarter analysis of 5 years shows Sanara MedTech's EBT Margin stood at 50.57% in 2021, then soared by 46bps to 27.18% in 2022, then surged by 95bps to 1.48% in 2023, then crashed by -1694bps to 26.62% in 2024, then skyrocketed by 116bps to 4.26% in 2025.
  • Its EBT Margin was 4.26% in Q3 2025, compared to 7.06% in Q2 2025 and 14.48% in Q1 2025.